Evidence map›Paper›PMID 26779384›Full record

ArticleJournal of biotechnology & biomaterials2015

Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts.

Chung-Wein Lee, Lili Guo, Daniela Matei, Keith Stantz

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of biotechnology & biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. PET Imaging of FSHR Expression in Tumors withContrast media & molecular imaging · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chung-Wein LeeMedical Physics Program, School of Health Science, Purdue University, West Lafayette, IN, USA.
Lili GuoDepartment of Medicine, Indiana University School of Medicine, Indianapolis IN, USA.
Daniela MateiDepartment of Medicine, Indiana University School of Medicine, Indianapolis IN, USA.
Keith StantzMedical Physics Program, School of Health Science, Purdue University, West Lafayette, IN, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis IN, USA.
Indiana University – Purdue University Indianapolis · USIndiana University School of Medicine

Funding

Photoacoustic CT for Preclinical Molecular ImagingR44CA102891 · NCI · OPTOSONICS, INC. · PI KRUGER, ROBERT A · 2003 to 2011
$4.5M
NCI NIH HHS R44 CA102891
6 · The paper itself

Abstract

The Follicle-Stimulating Hormone Receptor (FSHR) is used as an imaging biomarker for the detection of ovarian cancer (OC). FSHR is highly expressed on ovarian tumors and involved with cancer development and metastatic signaling pathways. A decapeptide specific to the FSHR extracellular domain is synthesized and conjugated to fluorescent dyes to image OC cells

Indexed as

DecapeptideFollicle-stimulating hormone receptorMultimeric peptideNear-infrared imagingOvarian cancer

Identifiers

PMID26779384
PMCPMC4712933
OpenAlexW2430594327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.